REGENXBIO Inc.

REGENXBIO Inc. - Current Ratioverified

RGNX

Price:

$7.8

Market Cap:

$403.24M

REGENXBIO Inc. is a biotechnology company operating in the clinical stage, dedicated to developing gene therapy candidates. These therapies are designed to introduce genes into cells, aiming either to rectify genetic deficiencies or to stimulate the body's own cells to produce therapeutic proteins or antibodies to combat diseases. Central to its therapeutic development is the proprietary NAV Technology Platform, an adeno-associated virus-based gene delivery system. The company's primary investigational asset, RGX-314, is currently in Phase III clinical trials for treating wet age-related macular degeneration. Its pipeline also includes RGX-121 and RGX-111, both in Phase I/II trials for mucop...[Read more]

Industry

Biotechnology

IPO Date

2015-09-17

Stock Exchange

NASDAQ

Ticker

RGNX

The Current Ratio as of June 2026 (TTM) for REGENXBIO Inc. (RGNX) is 2.62

According to REGENXBIO Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.62. This represents a change of -2.82% compared to the average of 2.70 of the last 4 quarters.

REGENXBIO Inc. (RGNX) Historical Current Ratio (quarterly & annually)

How has RGNX Current Ratio performed in the past?

The mean historical Current Ratio of REGENXBIO Inc. over the last ten years is 6.81. The current 2.62 Current Ratio has changed 3.75% with respect to the historical average. Over the past ten years (40 quarters), RGNX's Current Ratio was at its highest in in the September 2018 quarter at 20.21. The Current Ratio was at its lowest in in the December 2025 quarter at 2.38.

Quarterly (TTM)
Annual

Average

6.81

Median

5.25

Minimum

2.38

Maximum

15.24

REGENXBIO Inc. (RGNX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of REGENXBIO Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 30.95%

Maximum Annual Current Ratio = 15.24

Minimum Annual Increase = -64.54%

Minimum Annual Current Ratio = 2.38

Quarterly (TTM)
Annual
YearCurrent RatioChange
20252.38-11.59%
20242.694.77%
20232.57-19.37%
20223.19-19.80%
20213.98-39.03%
20206.52-36.34%
201910.25-32.76%
201815.2430.95%
201711.6420.50%
20169.66-64.54%

REGENXBIO Inc. (RGNX) Average Current Ratio

How has RGNX Current Ratio performed in the past?

The current Current Ratio of REGENXBIO Inc. (RGNX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.55

5-year avg

2.96

10-year avg

6.81

REGENXBIO Inc. (RGNX) Current Ratio vs. Peers

How is RGNX’s Current Ratio compared to its peers?

REGENXBIO Inc.’s Current Ratio is less than Absci Corporation (6.59), less than Verastem, Inc. (3.04), less than MoonLake Immunotherapeutics (8.60), less than Olema Pharmaceuticals, Inc. (10.88), less than 4D Molecular Therapeutics, Inc. (9.34), less than Ventyx Biosciences, Inc. (17.86), less than Prothena Corporation plc (10.43), less than Corvus Pharmaceuticals, Inc. (19.81), less than KalVista Pharmaceuticals, Inc. (5.58), greater than Gossamer Bio, Inc. (2.20),

Build a custom stock screener for REGENXBIO Inc. (RGNX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like REGENXBIO Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

REGENXBIO Inc. (RGNX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like REGENXBIO Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is REGENXBIO Inc.'s Current Ratio?

How is the Current Ratio calculated for REGENXBIO Inc. (RGNX)?

What is the highest Current Ratio for REGENXBIO Inc. (RGNX)?

What is the 3-year average Current Ratio for REGENXBIO Inc. (RGNX)?

What is the 5-year average Current Ratio for REGENXBIO Inc. (RGNX)?

How does the current Current Ratio for REGENXBIO Inc. (RGNX) compare to its historical average?